SecBot SecBot
144 ·Filed Apr 7, 2026

CYTK

CYTOKINETICS INC
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago SEC0001950047-26-003289
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for actual execution of the sale via future Form 4 filings; given the officer status and recent pattern of insider selling, this may signal routine portfolio management rather than negative sentiment. However, traders should watch for cumulative insider outflows over time.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$65.77
T+0 close · Apr 7, 2026 · via day close
Latest settled
+31.50%
T+60 · $86.49
Vs SPY
+21.05%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 8 $65.77entry
  2. T+1 · 7mo ago −1.79%α −2.37% · $64.59
  3. T+5 · 7mo ago −0.61%α −4.12% · $65.37
  4. T+20 · 7mo ago +17.21%α +8.67% · $77.09
  5. T+60 · 4mo ago +31.50%α +21.05% · $86.49
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Fady Malik, an officer at Cytokinetics, filed a Form 144 to notify intent to sell 22,000 shares of common stock, valued at approximately $1.43 million, acquired through stock option exercises. The filing is a routine notice of planned sales under Rule 144, with no indication of immediate market impact or unusual activity.

Key Facts

  • Fady Malik, an officer of Cytokinetics, filed Form 144 to sell up to 22,000 shares.
  • The shares are to be sold on the NASDAQ, with an approximate value of $1.43 million based on current market prices.
  • Shares were acquired through the exercise of stock options on March 9 and March 17, 2026, and will be sold for cash.
  • This is an advance notice of intent to sell; actual sale may not occur immediately or at all.
  • Recent insider activity shows $2.9M in insider sells over the past 30 days, indicating ongoing routine selling.

Financial Impact

$1.43 million in potential share sales (22,000 shares), representing a small fraction of the company's $8.0B market cap.

insider ownershippotential dilutionshare turnover

Risk Factors

  • Potential downward price pressure if the full 22,000 shares are sold quickly.
  • Perception of insider pessimism if combined with other negative catalysts, though standalone impact is minimal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-003289
Document: 0001950047-26-003289-index.html0001950047-26-003289
Document: 0001950047-26-003289.txt0001950047-26-003289

Track record

46 reports on CYTK

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +8.59% at T+20 after the Sep 15, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $53.76 Now $53.17 −1.10% settles Dec 15
  2. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.13 Now $53.17 −5.27% settles Dec 14
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
  4. Nov 9, 20267d ago 144 Neutral 2/10 Entry $56.18 Now $53.17 −5.36% settles Dec 9
  5. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
  6. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $55.14 Now $53.17 −3.57% settles Dec 8
  7. Nov 4, 202612d ago 8-K Bullish 6/10 No price data
  8. Nov 4, 202612d ago Press Release Neutral 5/10 Entry $55.55 Now $53.17 −4.28% settles Dec 4
  9. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $63.60 Now $53.17 −16.40% settles Dec 3
  10. Nov 2, 202614d ago Press Release Neutral 3/10 Entry $62.03 Now $53.17 −14.28% settles Dec 1
Showing 10 of 46

US Market Status

Market Closed · Opens Wed (11h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 7, 2026